Global Cytology and HPV Testing Market is Expected to Exceed Mor - Erie News Now | WICU & WSEE in Erie, PA

Global Cytology and HPV Testing Market is Expected to Exceed More Than US$ 10 Billion By 2024


The global cytology and HPV testing market is expected to exceed more than US$ 10 billion by 2024. The HPV testing market is projected to register a CAGR of more than 10% during the forecast period. The cytology testing market is projected to register a CAGR of around 5% between 2016 and 2024. The rising incidence of cervical cancer worldwide, the high occurrence rate of HPV infections, and increasing cervical cancer screening awareness programs are driving the market. However, the lack of appropriate primary healthcare infrastructure and low awareness of the global population are expected to hinder the growth of the market.

In this report, the global cytology and HPV testing market is segmented by product and services and region. On the basis of product and services, the market is segmented into HPV testing and cytology testing. The HPV testing and cytology testing segments are each subdivided into services, assay kits, and system.

The global cytology and HPV testing market is segmented on the basis of key regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is the largest cytology and HPV testing market. However, the market in Asia Pacific is expected to witness significant growth during the forecast period, primarily due to low-cost as well as immensely skilled labor. Furthermore, each region is segmented to provide market revenue for select countries such as the U.S., Canada, the U.K., Germany, China, Japan, Australia, Mexico, and Brazil. The report includes a detailed study of the global and regional cytology and HPV testing market and analyzes the variations in the growth of the industry in certain regions.

Becton, Dickinson and Company, Cepheid, Inc., Abbott Laboratories, Inc., F. Hoffmann-La Roche AG, Fujirebio Diagnostics, Inc., Arbor Vita Corporation, Hologic, Inc., QIAGEN N.V., and OncoHealth Corporation are the most active players in the cytology and HPV testing market.

A glimpse of the report structure is provided in the report description available on the website.

This report covers the cytology and HPV testing market, in terms of value, and forecasts the market size till 2024. In addition, the report identifies key growth segments and opportunities in the industry. This report also covers detailed competitive outlook including the share and company profiles of the key players in the global market. Company profile includes company summary, financial summary, business strategy and planning, SWOT analysis, and current developments.

This deep-dive study on the cytology and HPV testing market will help customers with the identification of new market opportunities and targeted promotional plans.


Media Contact

Company Name: Market Research Engine

Contact Person: John Bay


Phone: +1-855-984-1862

Country: United States




Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact

Powered by Frankly
3514 State St. Erie, PA 16508
Newsroom: (814) 454-8812
Business offices: (814) 454-5201
Share Stories
Submit your stories to our site!
Share Photos
Share your photos in our community galleries
RSS Feeds
All content © Copyright 2000 - 2017 WICU. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.
                   WICU/WSEE - 3514 State Street Erie, PA 16508 - (814) 454-5201 -